BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20251121T160254Z
CREATED:20251121T160254Z
LAST-MODIFIED:20251121T160254Z
UID:9564-1782086400-1782431999@thebiocalendar.com
SUMMARY:BIO 2026
DESCRIPTION:The industry’s premier event hosts thousands from across the global biotech ecosystem. Four days of programming\, networking\, Company Presentations\, and BIO Partnering™ focus on the future of our industry and make this a must-attend event. \n\n\n\n\n\n\nBIO 2026 is where we return to this essential “why.” It is our opportunity to reconnect as a global community\, to recharge our commitment\, and to remember that behind every innovation is a shared mission: to improve lives.
URL:https://thebiocalendar.com/event/bio-2026/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Investor,Networking,Partnering,Summit,Trade Show
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T100000
DTEND;TZID=America/Los_Angeles:20260624T140000
DTSTAMP:20260522T081810Z
CREATED:20260511T125831Z
LAST-MODIFIED:20260522T081810Z
UID:10409-1782295200-1782309600@thebiocalendar.com
SUMMARY:Bio-Expo Live: Downstream Bioprocessing
DESCRIPTION:Bioprocess Online’s Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Downstream Manufacturing session will have the chance to explore the newest equipment and solutions offered by our presenting suppliers essential to Therapeutic areas from ADCs to Vaccines. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies or contract manufacturers seeking available products/solutions to help them overcome downstream manufacturing challenges.
URL:https://thebiocalendar.com/event/bio-expo-live-downstream-bioprocessing-3/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-BEL-1280x720-downstream-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T110000
DTEND;TZID=America/Los_Angeles:20260624T120000
DTSTAMP:20260619T000220Z
CREATED:20260528T121712Z
LAST-MODIFIED:20260619T000220Z
UID:10532-1782298800-1782302400@thebiocalendar.com
SUMMARY:Global Regulatory Compliance for Aseptic Barrier Systems
DESCRIPTION:As sterile pharmaceutical manufacturing evolves\, isolators and Restricted Access Barrier Systems (RABS) have become central to contamination control strategies across global markets. Yet regulatory expectations from the FDA\, EU GMP Annex 1\, PIC/S\, and WHO differ in meaningful ways\, from legal enforceability to technical prescriptiveness\, creating compliance complexity for manufacturers supplying multiple markets. \nThis webinar provides a structured comparison of the four major regulatory frameworks governing aseptic barrier systems\, examining where they converge on scientific fundamentals and where they diverge in documentation requirements\, monitoring expectations\, and treatment of advanced technologies. Special focus will be given to the 2022 revision of EU GMP Annex 1 and its harmonized adoption across PIC/S and WHO. \nAttendees will leave with a clearer understanding of how to design and qualify barrier systems that satisfy both the principle-based flexibility of the FDA and the structured minimum standards of the EU/PIC/S/WHO model\, supporting a robust\, globally acceptable contamination control strategy. \nKEY LEARNING OBJECTIVES \n– Understand how FDA\, EU GMP Annex 1\, PIC/S\, and WHO align and differ in their requirements for isolators\, RABS\, and contamination control strategy documentation\n– Identify the practical compliance implications of regulatory divergence for manufacturers operating across multiple jurisdictions\n– Apply a risk-based framework for barrier system design\, decontamination validation\, and environmental monitoring that satisfies global inspection expectations
URL:https://thebiocalendar.com/event/global-regulatory-compliance-for-aseptic-barrier-systems/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-24-26-Esco-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T110000
DTEND;TZID=America/Los_Angeles:20260624T120000
DTSTAMP:20260619T000202Z
CREATED:20260615T144808Z
LAST-MODIFIED:20260619T000202Z
UID:10604-1782298800-1782302400@thebiocalendar.com
SUMMARY:Building Scalable Non-Viral Gene-Edited Cell Therapy Processes
DESCRIPTION:Join this webinar to learn how leading cell therapy developers are tackling one of the field’s biggest challenges: scaling non-viral gene-edited cell therapies from research to manufacturing. Through real-world data in T\, NK\, and CD34+ cells\, experts will demonstrate how electroporation can enable efficient CRISPR knock-out\, knock-in\, and transposon-based editing while preserving critical cell quality attributes. You’ll gain practical insights into optimizing gene delivery\, improving process consistency\, and building scalable\, GMP-ready workflows that support successful clinical and commercial development.
URL:https://thebiocalendar.com/event/building-scalable-non-viral-gene-edited-cell-therapy-processes/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/06-24-26-Lonza-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T150000
DTEND;TZID=America/Los_Angeles:20260624T180000
DTSTAMP:20260618T234915Z
CREATED:20260618T234914Z
LAST-MODIFIED:20260618T234915Z
UID:10630-1782313200-1782324000@thebiocalendar.com
SUMMARY:Unwind with WBD at The Lion's Share During BIO Week
DESCRIPTION:Womble Bond Dickinson invites you to drop by The Lion’s Share \, a beloved San Diego favorite with a speakeasy‑style vibe\, for a relaxed reception featuring appetizers\, drinks\, and great conversation. It’s an easy  – and enjoyable  – way to unwind and connect after a busy day at the conference.  \nWe look forward to raising a glass with you! \n#BIO2026
URL:https://thebiocalendar.com/event/unwind-with-wbd-at-the-lions-share-during-bio-week/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Social
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/9fa8b127a4844d309b3fddd9100a48fd.png
END:VEVENT
END:VCALENDAR